NCT04033042View on ClinicalTrials.gov

Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions for Use

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 18, 2019

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Diabetes Mellitus
Interventions
DEVICE

Prototype 0.5

Subjects will perform daily measurements on the IMD (Prototype 0.5) for 41 days.

Trial Locations (1)

89081

Institut für Diabetes-Technologie Forschungs- und Entwicklungs-gesellschaft mbH an der Universität Ulm (IDT), Ulm

All Listed Sponsors
collaborator

Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm

OTHER

lead

RSP Systems A/S

INDUSTRY

NCT04033042 - Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions for Use | Biotech Hunter | Biotech Hunter